Home
>
National Drug Code (NDC)
>
Vivelle Dot
Vivelle Dot - 0078-0345-45 - (estradiol)
Drug Information of Vivelle Dot
| Product NDC: | 0078-0345 |
| Proprietary Name: | Vivelle Dot |
| Non Proprietary Name: | estradiol |
| Active Ingredient(s): | .075 mg/d & nbsp; estradiol |
| Administration Route(s): | TRANSDERMAL |
| Dosage Form(s): | PATCH, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Vivelle Dot
| Product NDC: | 0078-0345 |
| Labeler Name: | Novartis Pharmaceuticals Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020538 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19990108 |
Package Information of Vivelle Dot
| Package NDC: | 0078-0345-45 |
| Package Description: | 3 PACKET in 1 CARTON (0078-0345-45) > 8 POUCH in 1 PACKET (0078-0345-42) > 1 PATCH in 1 POUCH (0078-0345-62) > 3.5 d in 1 PATCH |
NDC Information of Vivelle Dot
| NDC Code | 0078-0345-45 |
| Proprietary Name | Vivelle Dot |
| Package Description | 3 PACKET in 1 CARTON (0078-0345-45) > 8 POUCH in 1 PACKET (0078-0345-42) > 1 PATCH in 1 POUCH (0078-0345-62) > 3.5 d in 1 PATCH |
| Product NDC | 0078-0345 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | estradiol |
| Dosage Form Name | PATCH, EXTENDED RELEASE |
| Route Name | TRANSDERMAL |
| Start Marketing Date | 19990108 |
| Marketing Category Name | NDA |
| Labeler Name | Novartis Pharmaceuticals Corporation |
| Substance Name | ESTRADIOL |
| Strength Number | .075 |
| Strength Unit | mg/d |
| Pharmaceutical Classes | Estradiol Congeners [Chemical/Ingredient],Estrogen [EPC],Estrogen Receptor Agonists [MoA] |
